Significant association between DRD3 gene body methylation and schizophrenia

Psychiatry Research

Volumn 220, Issue 3, 2014, Pages 772-777

  Dai, Dongjun ^a   Cheng, Jia ^b   Zhou, Kena ^a   Lv, Yuelong ^a   Zhuang, Qidong ^a   Zheng, Rongjiong ^a   Zhang, Kai ^a   Jiang, Danjie ^a   Gao, Shugui ^b   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b Ningbo Kangning Hospital   (China)

Author keywords

Dopamine system; Epigenetic; Gender difference; Paranoid; Undifferentiated

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CPG2 GENE; CPG3 GENE; CPG5 GENE; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; DNA METHYLATION; DOPAMINERGIC SYSTEM; DRD3 GENE; EPIGENETICS; FEMALE; GENE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SEX DIFFERENCE; SYMPTOMATOLOGY; GENETICS; METABOLISM; METHYLATION; PHYSIOLOGY; PROCEDURES;

DOPAMINE 3 RECEPTOR; DRD3 PROTEIN, HUMAN;

ADULT; DNA METHYLATION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; METHYLATION; RECEPTORS, DOPAMINE D3; SCHIZOPHRENIA;

EID: 84919701564     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.08.032     Document Type: Article

References (50)

1. Abdolmaleky H.M., Nohesara S., Ghadirivasfi M., Lambert A.W., Ahmadkhaniha H., Ozturk S., Wong C.K., Shafa R., Mostafavi A., Thiagalingam S. DNA hypermethylation of serotonin transporter gene promoter in drug naive patients with schizophrenia. Schizophrenia Research 2014, 152:373-380.
2. Akabaliev V.H., Sivkov S.T. Sexual dimorphism in minor physical anomalies in schizophrenic patients and normal controls. Comprehensive Psychiatry 2003, 44:341-348.
3. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV-TR.
4. Ball M.P., Li J.B., Gao Y., Lee J.H., LeProust E.M., Park I.H., Xie B., Daley G.Q., Church G.M. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nature Biotechnology 2009, 27:361-368.
5. Beratis S., Gabriel J., Hoidas S. Age at onset in subtypes of schizophrenic disorders. Schizophrenia Bulletin 1994, 20:287-296.
6. Beratis S., Gabriel J., Hoidas S. Gender differences in the frequency of schizophrenic subtypes in unselected hospitalized patients. Schizophrenia Research 1997, 23:239-244.
7. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., Venturi P., Jones L.A., Lewis S.W., Sham P.C., Gottesman I.I., Farmer A.E., McGuffin P., Reveley A.M., Murray R.M. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Archives of General Psychiatry 1999, 56:162-168.
8. Carlsson A., Hansson L.O., Waters N., Carlsson M.L. Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications. Life Sciences 1997, 61:75-94.
9. Chen C., Wang L., Liao Q., Huang Y., Ye H., Chen F., Xu L., Ye M., Duan S. Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Diagnostic Pathology 2013, 8:199.
10. Cheng J., Wang L., Xu L., Wang H., Liu P., Bu S., Ye M., Zhang L., Wang Q., Duan S. Gender-dependent miR-375 promoter methylation and the risk of type 2 diabetes. Experimental and Therapeutic Medicine 2013, 5:1687-1692.
11. Cheng J., Wang Y., Zhou K., Wang L., Li J., Zhuang Q., Xu X., Xu L., Zhang K., Dai D., Zheng R., Li G., Zhang A., Gao S., Duan S. Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. PloS One 2014, 9:e89128.
12. Cohen J.D., Servan-Schreiber D. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophrenia Bulletin 1993, 19:85-104.
13. Do K.Q. [Schizophrenia: genes, environment and neurodevelopment]. Revue Medicale Suisse 2013, 9(1672):1674-1677.
14. Fanous A.H., Kendler K.S. Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature. Current Psychiatry Reports 2008, 10:164-170.
15. Feigenson K.A., Kusnecov A.W., Silverstein S.M. Inflammation and the two-hit hypothesis of schizophrenia. Neuroscience and Biobehavioral Reviews 2014, 38:72-93.
16. Furuya T.K., da Silva P.N., Payao S.L., Rasmussen L.T., de Labio R.W., Bertolucci P.H., Braga I.L., Chen E.S., Turecki G., Mechawar N., Mill J., de Arruda Cardoso Smith M. SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer[U+05F3]s disease. Neurochemistry International 2012, 61:973-975.
17. Geoffroy P.A., Etain B., Houenou J. Gene X environment interactions in schizophrenia and bipolar disorder: evidence from neuroimaging. Frontiers in Psychiatry 2013, 4:136.
18. Godlewska B.R., Olajossy-Hilkesberger L., Limon J., Landowski J. Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients. Psychiatry Research 2010, 177:266-267.
19. Grundberg E., Meduri E., Sandling J.K., Hedman A.K., Keildson S., Buil A., Busche S., Yuan W., Nisbet J., Sekowska M., Wilk A., Barrett A., Small K.S., Ge B., Caron M., Shin S.Y., Lathrop M., Dermitzakis E.T., McCarthy M.I., Spector T.D., Bell J.T., Deloukas P. Global analysis of DNA methylation variation in adipose tissue from twins reveals links to disease-associated variants in distal regulatory elements. American Journal of Human Genetics 2013, 93:876-890.
20. Gurevich E.V., Bordelon Y., Shapiro R.M., Arnold S.E., Gur R.E., Joyce J.N. Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. Archives of General Psychiatry 1997, 54:225-232.
21. Henikoff S., Matzke M.A. Exploring and explaining epigenetic effects. Trends in Genetics: TIG 1997, 13:293-295.
22. Hosak L. New findings in the genetics of schizophrenia. World Journal of Psychiatry 2013, 3:57-61.
23. Ilani, T., Ben-Shachar, D., Strous, R.D., Mazor, M., Sheinkman, A., Kotler, M., Fuchs, S., 2001. A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 98, 625-628.
24. Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. European Archives of Psychiatry and Clinical Neuroscience 2000, 250:274-285.
25. Jiang D., Hong Q., Shen Y., Xu Y., Zhu H., Li Y., Xu C., Ouyang G., Duan S. The diagnostic value of DNA methylation in leukemia: a systematic review and meta-analysis. PloS One 2014, 9:e96822.
26. Jiang D., Zheng D., Wang L., Huang Y., Liu H., Xu L., Liao Q., Liu P., Shi X., Wang Z., Sun L., Zhou Q., Li N., Le Y., Ye M., Shao G., Duan S. Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PloS One 2013, 8:e59752.
27. Jimenez J.A., Mancini-Marie A., Lakis N., Rinaldi M., Mendrek A. Disturbed sexual dimorphism of brain activation during mental rotation in schizophrenia. Schizophrenia Research 2010, 122:53-62.
28. Kendler K.S., McGuire M., Gruenberg A.M., O'Hare A., Spellman M., Walsh D. The Roscommon family study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Archives of General Psychiatry 1993, 50:527-540.
29. Kinoshita M., Numata S., Tajima A., Shimodera S., Ono S., Imamura A., Iga J., Watanabe S., Kikuchi K., Kubo H., Nakataki M., Sumitani S., Imoto I., Okazaki Y., Ohmori T. DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromolecular Medicine 2013, 15:95-101.
30. Kordi-Tamandani D.M., Sahranavard R., Torkamanzehi A. Analysis of association between dopamine receptor genes[U+05F3] methylation and their expression profile with the risk of schizophrenia. Psychiatric Genetics 2013, 23:183-187.
31. Laurent L., Wong E., Li G., Huynh T., Tsirigos A., Ong C.T., Low H.M., Kin Sung K.W., Rigoutsos I., Loring J., Wei C.L. Dynamic changes in the human methylome during differentiation. Genome Research 2010, 20:320-331.
32. Lecardeur L., Mendrek A., Stip E. Sexual dimorphism of spatial working memory profiles in schizophrenia. Cognitive Neuropsychiatry 2010, 15:397-405.
33. Lindamer L.A., Lohr J.B., Harris M.J., Jeste D.V. Gender, estrogen, and schizophrenia. Psychopharmacology Bulletin 1997, 33:221-228.
34. Lochman J., Balcar V.J., Stastny F., Sery O. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory regions of the ADRA2A, DRD3 and SNAP-25 genes. Psychiatry Research 2013, 205:7-12.
35. Masliah E., Dumaop W., Galasko D., Desplats P. Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes. Epigenetics: Official Journal of the DNA Methylation Society 2013, 8:1030-1038.
36. McGrath J.J., Mortensen P.B., Visscher P.M., Wray N.R. Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophrenia Bulletin 2013, 39:955-959.
37. Mill J., Tang T., Kaminsky Z., Khare T., Yazdanpanah S., Bouchard L., Jia P., Assadzadeh A., Flanagan J., Schumacher A., Wang S.C., Petronis A. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. American Journal of Human Genetics 2008, 82:696-711.
38. Mulle J.G. Schizophrenia genetics: progress, at last. Current Opinion in Genetics & Development 2012, 22:238-244.
39. Penaloza C.G., Estevez B., Han D.M., Norouzi M., Lockshin R.A., Zakeri Z. Sex-dependent regulation of cytochrome P450 family members Cyp1a1, Cyp2e1, and Cyp7b1 by methylation of DNA. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 2013, 28.
40. Piferrer F. Epigenetics of sex determination and gonadogenesis. Developmental Dynamics: An Official Publication of the American Association of Anatomists 2013, 242:360-370.
41. Razin A., Webb C., Szyf M., Yisraeli J., Rosenthal A., Naveh-Many T., Sciaky-Gallili N., Cedar H. Variations in DNA methylation during mouse cell differentiation in vivo and in vitro. Proceedings of the National Academy of Sciences of the United States of America 1984, 81:2275-2279.
42. Schmauss C., Haroutunian V., Davis K.L., Davidson M. Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:8942-8946.
43. Singh S., Kumar A., Agarwal S., Phadke S.R., Jaiswal Y. Genetic insight of schizophrenia: past and future perspectives. Gene 2014, 535:97-100.
44. Talkowski M.E., Mansour H., Chowdari K.V., Wood J., Butler A., Varma P.G., Prasad S., Semwal P., Bhatia T., Deshpande S., Devlin B., Thelma B.K., Nimgaonkar V.L. Novel, replicated associations between dopamine D3 receptor gene polymorphisms and schizophrenia in two independent samples. Biological Psychiatry 2006, 60:570-577.
45. Tang L.L., Liu Q., Bu S.Z., Xu L.T., Wang Q.W., Mai Y.F., Duan S.W. The effect of environmental factors and DNA methylation on type 2 diabetes mellitus. Yi chuan=Hereditas/Zhongguo yi chuan xue hui bian ji 2013, 35:1143-1152.
46. Tee S., Tang P., Loh H. Genetic association analysis of dopamine DRD3 Ser9Gly polymorphism and schizophrenia in Malay population. Iranian Journal of Public Health 2011, 40:6-10.
47. Urraca N., Camarena B., Aguilar A., Fresan A., Apiquian R., Orozco L., Carnevale A., Nicolini H. Association study of DRD3 gene in schizophrenia in Mexican sib-pairs. Psychiatry Research 2011, 190:367-368.
48. Vehof J., Burger H., Wilffert B., Al Hadithy A., Alizadeh B.Z., Snieder H., investigators G. Clinical response to antipsychotic drug treatment: association study of polymorphisms in six candidate genes. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 2012, 22:625-631.
49. Xu H., Wang B., Su D., Yu Q., Li Q., Kou C., Shi J., Yu Y., Ma X. The DNA methylation profile of PLA2G4C gene promoter in schizophrenia. Psychiatry Research 2012, 200:1079-1081.
50. Xu L., Zheng D., Wang L., Jiang D., Liu H., Liao Q., Zhang L., Liu P., Shi X., Wang Z., Sun L., Zhou Q., Li N., Huang Y., Le Y., Ye M., Shao G., Duan S. GCK gene-body hypomethylation is associated with the risk of coronary heart disease. BioMed Research International 2014, 2014:151723.